Journal of Surgery

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Surgical Treatment of Malignant Soft Tissue Tumors at the Oncological Surgery Unit of Conakry

Introduction: Malignant soft tissue tumours (MSCTs) are mainly represented by sarcomas, and their incidence varies. The aim of this study was to describe the surgical treatment of MPMT in the surgical oncology unit of the Donka National Hospital. Materials and Methods: This was a retrospective study carried out over a period of 14 years (2007 to 2021), covering patients with histologically confirmed malignant soft tissue tumours who had received specific treatment. Results: We compiled 83 records of patients with histologically confirmed soft tissue tumours, 12 (14.4%) of whom were treated surgically and 15 (18.1%) medically with chemotherapy. The mean age was 39.4 years. The 40-49 age group accounted for 6 (22.2%) cases. Women predominated in 14 (51.8%) cases. The average consultation time was 26.2 months. The thigh and the knee were the sites represented in 7 (26.0%) and 6 (22.2%) cases respectively. Fibrosarcoma was the most common histological type in 12 (44.4%) cases, followed by rhabdomyosarcoma in 9 (33.3%) cases. Clinical stages III and VI accounted for 13 (48.1%) and 8 (29.6%) cases respectively. Seven (58.3%) cases underwent wide excision and 5 (41.7%) cases underwent amputation. Node dissection was inguinal in 5 (100.0%) cases. Resection was R0 in 8 (66.6%) cases. Post-operative follow-up was good in 11 (91.6%) cases. One case of lymphoedema of the limb and chronic pain was recorded. Conclusion: The management of malignant soft tissue tumours is fraught with difficulties in our context, as the diagnosis is usually made at a late stage. Early, planned and correctly performed initial surgical treatment has a major impact on prognosis.

Malignant Soft Tissue Tumours, Surgery, Conakry University Hospital

Malick Bah, Toure Alhassane Ismael, Keita Mamady, Souare Mamadou Bobo, Cisse Ibrahima Kalil Conde, et al. (2023). Surgical Treatment of Malignant Soft Tissue Tumors at the Oncological Surgery Unit of Conakry. Journal of Surgery, 11(5), 107-112.

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Adigun IA, Rahman GA. A review of soft tissue sarcoma. Niger J Med 2007; 16: 94-101.
2. Casali PG, Blay J-Y, ESMO/CONTICANET/EUROBONET Consensus Panel of experts. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 Suppl 5: v198-203.
3. American Cancer Society. Cancer Facts & Figures 2020. Atlanta: American Cancer Society 2020. (accessed June 19, 2020).
4. Bonvalot S, Vanel D, Terrier P, Le Pechoux C, Le Cesne A. Principles of treatment of soft tissue sarcomas in adults. EMC - Rheumatology-Orthopaedics 2004; 1: 521-41.
5. Levy AD, Manning MA, Al-Refaie WB, Miettinen MM. Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 1-Common Sarcomas: From the Radiologic Pathology Archives. Radiographics 2017; 37: 462–83.
6. De La Hoz Polo M, Dick E, Bhumbra R, Pollock R, Sandhu R, Saifuddin A. Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs. Skeletal Radiol 2017; 46: 1667-78.
7. Stoeckle E, Michot A, Henriques B, Sargos P, Honoré C, Ferron G, et al. Surgery of limb and trunk wall soft tissue sarcomas. Cancer/Radiothérapie 2016; 20: 657–65.
8. Kouassi KKY, Touré M, Séka EN, Traoré M, Traoré K, Oséni A, et al. Regard sur la prise en charge des sarcomes des tissus mous (STM): Expérience du service de cancérologie du CHU de Treichville. Rev Int Sc Méd 2017; 19: 185-90.
9. Diakité A, Bouras Y, Essarouali A, Bennouna D, Fadili M, Ouarab M. Management of limb soft tissue sarcomas (about 30 cases). Rev Maroc Chir Orthop Traumato 2011; 45: 15-20.
10. Abdou J, Elkabous M, M'rabti H, Errihani H. Soft tissue sarcomas: about 33 cases. Pan Afr Med J 2015; 22.
11. Djehal N, Filali T. Soft tissue sarcomas: a demographic, diagnostic and therapeutic study. Algerian Journal of Medicine 2019; 27.
12. Honoré C, Méeus P, Stoeckle E, Bonvalot S. Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care. J Visc Surg 2015; 152: 223-30.
13. Li Y, Niu X, Xu H. Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity. Zhonghua Wai Ke Za Zhi 2011; 49: 964-9.
14. Fletcher CDM, World Health Organization, International Agency for Research on Cancer, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.
15. Jakob J, Hohenberger P. Principles of sarcoma surgery. Pathologe 2019; 40: 431–5.
16. Verhaeghe J, Rios M, Leroux A, Sirveaux F, Henrot P, Blum A, et al. Treatment of adult soft tissue sarcomas: which strategy to optimise treatment. E-Mémoires de l'Académie Nationale de Chirurgie 2011; 10: 48-53.
17. Grabellus F, Podleska LE, Sheu S-Y, Bauer S, Pöttgen C, Kloeters C, et al. Neoadjuvant treatment improves capsular integrity and the width of the fibrous capsule of high-grade soft-tissue sarcomas. Eur J Surg Oncol 2013; 39: 61-7.
18. Baldini EH, Lapidus MR, Wang Q, Manola J, Orgill DP, Pomahac B, et al. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol 2013; 20: 1494-9.
19. Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma 2010; 2010: 506182.
20. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma Version 2. 2022 2022. (accessed January 16, 2023).